Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Preventative medicine: genetic screening of inherited diseases
Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers.
An Unlikely Alliance – Could PBMs and diagnosis labs find synergies in the healthcare market?
The Challenges of Patenting Precision Medicine in the Era of Mayo and Myriad
Takeda using Advanced Machine Learning to find insights about NASH & TRD
Enabling Genomics – Guided Precision Medicine with Real World Evidence
Neurodegenerative diseases and the microbiome: lessons learned from mouse models
Tweets
Congratulations Grace - absolutely thrilled to have you Keynote at the Precision Medicine Leaders Summit June 11-12… https://t.co/8UKLCzCUJK, - @pmlsevents,
- Interesting commentary and study results from TFS -Tumor mutation burden (TMB) study shows viability of in-house te… https://t.co/DZ0qbXjPMt,